Supplementary Data from A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Methods, Tables and Figures
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361887839
